Previous close | 1.7600 |
Open | 1.7700 |
Bid | 1.2700 x 200 |
Ask | 2.2400 x 200 |
Day's range | 1.7475 - 1.8000 |
52-week range | 1.1600 - 3.3800 |
Volume | |
Avg. volume | 253,935 |
Market cap | 142.354M |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Q1 2024 Summit Therapeutics Inc Earnings Call
I-Mab ( NASDAQ:IMAB ) Full Year 2023 Results Key Financial Results Net loss: CN¥1.47b (loss narrowed by 39% from FY...
Q4 2023 Summit Therapeutics Inc Earnings Call